99 related articles for article (PubMed ID: 6609536)
21. Biochemical pharmacology and toxicology of formycin alone and in combination with 2'-deoxycoformycin (pentostatin).
Spremulli EN; Crabtree GW; Dexter DL; Chu SH; Farineau DM; Ghoda LY; McGowan DL; Diamond I; Parks RE; Calabresi P
Cancer Treat Rep; 1983 Mar; 67(3):267-74. PubMed ID: 6600968
[TBL] [Abstract][Full Text] [Related]
22. 2'-Deoxycoformycin-induced hemolysis in the mouse.
Spremulli E; Crabtree GW; Dexter DL; Diamond I; Calabresi P
J Natl Cancer Inst; 1982 Jun; 68(6):1011-4. PubMed ID: 6979651
[TBL] [Abstract][Full Text] [Related]
23. Clinical pharmacology of arabinofuranosyladenine in combination with deoxycoformycin.
Major PP; Agarwal RP; Kufe DW
Cancer Chemother Pharmacol; 1983; 10(2):125-8. PubMed ID: 6600984
[No Abstract] [Full Text] [Related]
24. Induction of complete remission in T-cell acute lymphoblastic leukemia with deoxycoformycin (dcf) and 9-beta-D-arabinofuranosyladenine (ara-A).
Yu AL; Mendelsohn J; Matsumoto SS
Adv Exp Med Biol; 1986; 195 Pt A():491-6. PubMed ID: 3487920
[No Abstract] [Full Text] [Related]
25. 2'-deoxycoformycin. A new anticancer agent.
Poster DS; Penta JS; Bruno S; Macdonald JS
Cancer Clin Trials; 1981; 4(2):209-13. PubMed ID: 7018725
[TBL] [Abstract][Full Text] [Related]
26. Biochemical consequences of adenosine deaminase inhibition in vivo. Differential effects in acute and chronic T cell leukemia.
Mitchell BS; Sidi Y; Hershfield M; Koller CA
Ann N Y Acad Sci; 1985; 451():129-37. PubMed ID: 3878114
[No Abstract] [Full Text] [Related]
27. The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.
Matsumoto SS; Yu J; Yu AL
J Biol Chem; 1988 May; 263(15):7153-8. PubMed ID: 3259231
[TBL] [Abstract][Full Text] [Related]
28. The treatment of hairy cell leukemia (HCL) with pentostatin (2'-deoxycoformycin, dCF).
Spiers AS; Parekh SJ
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():173-5. PubMed ID: 2653498
[No Abstract] [Full Text] [Related]
29. Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
Adv Exp Med Biol; 1986; 195 Pt B():683-7. PubMed ID: 3490130
[No Abstract] [Full Text] [Related]
30. Modulation of arabinosyladenine metabolism by 2'-deoxycoformycin in the therapy of human acute leukemia.
Plunkett W; Nowak B; Feun LG; Benjamin RS; Keating M; Freirich EJ
Adv Exp Med Biol; 1984; 165 Pt B():345-50. PubMed ID: 6372382
[No Abstract] [Full Text] [Related]
31. Evidence for distinct catabolic pathways of adenine ribonucleotides and deoxyribonucleotides in human T lymphoblastoid cells.
Barankiewicz J; Cohen A
J Biol Chem; 1984 Dec; 259(24):15178-81. PubMed ID: 6334686
[TBL] [Abstract][Full Text] [Related]
32. ATP depletion as a consequence of adenosine deaminase inhibition in man.
Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
[TBL] [Abstract][Full Text] [Related]
33. [Successful treatment with 2'-deoxycoformycin in a case of adult T-cell leukemia].
Ishii M; Yamaguchi K; Yul LS; Oda T; Takatsuki K
Rinsho Ketsueki; 1986 May; 27(5):780-3. PubMed ID: 3018324
[No Abstract] [Full Text] [Related]
34. 2-Deoxycoformycin inhibition of intracellular phosphorylation of adenosine in Novikoff rat hepatoma cells.
Plagemann PG; Wohlhueter RM
Biochem Pharmacol; 1981 Mar; 30(5):417-26. PubMed ID: 6971643
[No Abstract] [Full Text] [Related]
35. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
Yu AL; Bakay B; Kung FH; Nyhan WL
Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
[TBL] [Abstract][Full Text] [Related]
36. Deoxycoformycin toxicity in mice after long-term treatment.
Agarwal RP
Cancer Chemother Pharmacol; 1980; 5(2):83-7. PubMed ID: 6970629
[TBL] [Abstract][Full Text] [Related]
37. Deoxycoformycin in the treatment of leukemias and lymphomas.
Smyth JF; Prentice HG; Proctor S; Hoffbrand AV
Ann N Y Acad Sci; 1985; 451():123-8. PubMed ID: 3878113
[TBL] [Abstract][Full Text] [Related]
38. Studies on the biochemical sequelae of therapy in Thy-acute lymphoblastic leukaemia with the adenosine deaminase inhibitor 2' deoxycoformycin.
Russell NH; Prentice HG; Lee N; Piga A; Ganeshaguru K; Smyth JF; Hoffbrand AV
Br J Haematol; 1981 Sep; 49(1):1-9. PubMed ID: 6974003
[TBL] [Abstract][Full Text] [Related]
39. Association of severe and fatal infections and treatment with pentostatin.
O'Dwyer PJ; Spiers AS; Marsoni S
Cancer Treat Rep; 1986 Sep; 70(9):1117-20. PubMed ID: 3488805
[TBL] [Abstract][Full Text] [Related]
40. Inhibitor of 2',5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
Biochem Biophys Res Commun; 1985 Mar; 127(3):1019-25. PubMed ID: 3872657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]